Core Laboratories (CLB) Tops Q4 EPS by 1c
Core Laboratories (NYSE: CLB) reported Q4 EPS of $0.19, $0.01 better than the analyst estimate of $0.18. Revenue for the quarter came in at $128.2 million versus the consensus estimate of $125.1 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
